Business Description
3D Global Biotech Inc
ISIN : TW0006808009
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 16 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.29 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 34.17 | |||||
Beneish M-Score | -2.59 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14 | |||||
3-Year EBITDA Growth Rate | -12.4 | |||||
3-Year EPS without NRI Growth Rate | -5 | |||||
3-Year FCF Growth Rate | -10 | |||||
3-Year Book Growth Rate | -14.7 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.37 | |||||
9-Day RSI | 48.73 | |||||
14-Day RSI | 50.6 | |||||
6-1 Month Momentum % | 57.07 | |||||
12-1 Month Momentum % | 10.28 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.63 | |||||
Quick Ratio | 6.49 | |||||
Cash Ratio | 6.27 | |||||
Days Inventory | 81.02 | |||||
Days Sales Outstanding | 36.67 | |||||
Days Payable | 53.64 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | -0.2 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 25.56 | |||||
Operating Margin % | -304.62 | |||||
Net Margin % | -280.87 | |||||
FCF Margin % | -156.99 | |||||
ROE % | -18.37 | |||||
ROA % | -16.77 | |||||
ROIC % | -38.28 | |||||
ROC (Joel Greenblatt) % | -344.41 | |||||
ROCE % | -18.19 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 87.77 | |||||
PB Ratio | 6.25 | |||||
Price-to-Tangible-Book | 9.58 | |||||
EV-to-EBIT | -28.12 | |||||
EV-to-EBITDA | -46.08 | |||||
EV-to-Revenue | 80.06 | |||||
EV-to-FCF | -51 | |||||
Price-to-Net-Current-Asset-Value | 12.67 | |||||
Price-to-Net-Cash | 13.57 | |||||
Earnings Yield (Greenblatt) % | -3.56 | |||||
FCF Yield % | -1.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
3D Global Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 20.633 | ||
EPS (TTM) (NT$) | -1.031 | ||
Beta | 0.67 | ||
Volatility % | 53.22 | ||
14-Day RSI | 50.6 | ||
14-Day ATR (NT$) | 1.420239 | ||
20-Day SMA (NT$) | 32.61 | ||
12-1 Month Momentum % | 10.28 | ||
52-Week Range (NT$) | 17.2 - 40.15 | ||
Shares Outstanding (Mil) | 55.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
3D Global Biotech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
3D Global Biotech Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
3D Global Biotech Inc Frequently Asked Questions
What is 3D Global Biotech Inc(ROCO:6808)'s stock price today?
When is next earnings date of 3D Global Biotech Inc(ROCO:6808)?
Does 3D Global Biotech Inc(ROCO:6808) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |